Reaction

Hyperlipasaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 518 reports · 8 co-occurring drugs

As of the last recalculation, Hyperlipasaemia appears in 518 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (PRR 30.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Sitagliptin And Metformin Hydrochloride1630.730.7
Dronabinol630.330.3
Dapagliflozin1722.422.4
Durvalumab1020.120.1
Ethyl Alcohol1116.616.6
Pegaspargase516.616.6
Alcohol1111.611.6
Dulaglutide209.49.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.